Success Story Hennig Arzneimittel GmbH & Co. KG: Without risks and side effects

Success Story Hennig Arzneimittel GmbH & Co. KG Without risks and side effects

You already know our previous success stories? Now another success story by our customer Hennig Arzneimittel is available.

The title “Without risks and side effects” makes you curious? Read the exciting success story of Hennig Arzneimittel with the friendly support of Digital Life Sciences GmbH.

This success storty tells you how the family business Hennig Arzneimittel benefits from a modern eDMS/eQMS, how an outdated DMS hindered everyday work and how the new system made the tedious paper backups a thing of the past. Furthermore, you can expect an insight into how far the migration support of Digital Life Sciences facilitated the changeover to the new solution and how Hennig Arzneimittel was able to optimize its processes with out “Training Management” solution.

Share now!

Subscribe to the newsletter

You want to stay up to date? Then subscribe to our newsletter.
Image ILMAC — Visit Digital Life Sciences
News

Visit us at the ILMAC 2025 in Basel

ILMAC 2025 is the most important industry meeting place for chemical and life science companies in Switzerland. From September 16-18, 2025, the latest trends and

BM-Flow reaches end-of-life – what now
Blog

BM-Flow reaches end-of-life – what now?

Table of Contents BM-Flow reaches end-of-life – what now? Why future-proof eQMS systems are crucial and how to act now biomedion GmbH has finally discontinued

You want to digitalize your business?

Leave a message. We will get back to you!

Portrait of employees discussing in the office